These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 21295057

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Catecholamine influences on dorsolateral prefrontal cortical networks.
    Arnsten AF.
    Biol Psychiatry; 2011 Jun 15; 69(12):e89-99. PubMed ID: 21489408
    [Abstract] [Full Text] [Related]

  • 3. Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction.
    Arnsten AF.
    CNS Drugs; 2009 Jun 15; 23 Suppl 1():33-41. PubMed ID: 19621976
    [Abstract] [Full Text] [Related]

  • 4. Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.
    Arnsten AF.
    J Clin Psychiatry; 2006 Jun 15; 67 Suppl 8():7-12. PubMed ID: 16961424
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mechanism of action of guanfacine: a postsynaptic differential approach to the treatment of attention deficit hyperactivity disorder (adhd).
    Alamo C, López-Muñoz F, Sánchez-García J.
    Actas Esp Psiquiatr; 2016 May 15; 44(3):107-12. PubMed ID: 27254403
    [Abstract] [Full Text] [Related]

  • 10. Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors.
    Gamo NJ, Wang M, Arnsten AF.
    J Am Acad Child Adolesc Psychiatry; 2010 Oct 15; 49(10):1011-23. PubMed ID: 20855046
    [Abstract] [Full Text] [Related]

  • 11. Psychostimulants and atomoxetine alter the electrophysiological activity of prefrontal cortex neurons, interaction with catecholamine and glutamate NMDA receptors.
    Di Miceli M, Gronier B.
    Psychopharmacology (Berl); 2015 Jun 15; 232(12):2191-205. PubMed ID: 25572531
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Stimulants: Therapeutic actions in ADHD.
    Arnsten AF.
    Neuropsychopharmacology; 2006 Nov 15; 31(11):2376-83. PubMed ID: 16855530
    [Abstract] [Full Text] [Related]

  • 17. The Emerging Neurobiology of Attention Deficit Hyperactivity Disorder: The Key Role of the Prefrontal Association Cortex.
    Arnsten AF.
    J Pediatr; 2009 May 01; 154(5):I-S43. PubMed ID: 20596295
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of action of agents used in attention-deficit/hyperactivity disorder.
    Wilens TE.
    J Clin Psychiatry; 2006 May 01; 67 Suppl 8():32-8. PubMed ID: 16961428
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.